Deprescribing trials need a rationale-first framework before choosing trial design

Catherine S Hwang, Kenneth S Boockvar, Michael A Steinman

Open source

DOI: 10.1016/j.lanhl.2026.100893
Published: 2026-08
Container: The Lancet Healthy Longevity
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanhl.2026.100893,
  title = {Deprescribing trials need a rationale-first framework before choosing trial design},
  author = {Catherine S Hwang and Kenneth S Boockvar and Michael A Steinman},
  year = {2026},
  journal = {The Lancet Healthy Longevity},
  doi = {10.1016/j.lanhl.2026.100893},
  url = {https://doi.org/10.1016/j.lanhl.2026.100893}
}

RIS

TY  - JOUR
TI  - Deprescribing trials need a rationale-first framework before choosing trial design
AU  - Catherine S Hwang
AU  - Kenneth S Boockvar
AU  - Michael A Steinman
PY  - 2026
JO  - The Lancet Healthy Longevity
DO  - 10.1016/j.lanhl.2026.100893
UR  - https://doi.org/10.1016/j.lanhl.2026.100893
ER  -

APA

Hwang, C. S., Boockvar, K. S., & Steinman, M. A. (2026). Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity. https://doi.org/10.1016/j.lanhl.2026.100893

Source records

crossref · retrieved 2026-09-25T08:39:32.596Z